Parham Zarrini is a Cardiology physician affiliated with Cedars-Sinai Smidt Heart Institute. OpenAlex indexes 26 publications with 395 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9100 Wilshire Blvd Ste 363w
Beverly Hills, CA 902123464
Telephone
310-928-8210Provider last certified this registry record 14 Dec 2022.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20259 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20254 payments
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.4%Statin17.8%Atorvastatin Calcium55%Rosuvastatin Calcium45%Part D≥65 patientsBeta blocker11.8%Metoprolol Succinate53%Carvedilol47%Part D≥40 patients+ 12 more classes in this area
Blood & clotting
12.5%Factor Xa inhibitor9.7%Eliquis72%Xarelto28%Part D<11 patientsP2Y12 inhibitor2.2%Clopidogrel100%Part D≥12 patients+ 1 more class in this area
Metabolism & gastrointestinal
9.1%SGLT2 inhibitor6.1%Jardiance74%Farxiga26%Part D≥20 patientsGLP-1 receptor agonist1.1%Mounjaro100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cold pressor testing and sympathetic nervous system contribution to ischemia with no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Project
American Heart Journal Plus Cardiology Research and Practice
2021 - Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease
American Heart Journal Plus Cardiology Research and Practice
2021 - MYOCARDIAL SCAR PATTERNS IN WOMEN WITH SUSPECTED CORONARY VASOMOTOR DYSFUNCTION: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION
Journal of the American College of Cardiology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Aakriti Gupta, MD, BS
Cedars-Sinai Smidt Heart Institute
Joshua Goldhaber, MD
Cedars-Sinai Smidt Heart Institute
Janet Wei, MD
Cedars-Sinai Smidt Heart Institute
Eugenio Cingolani, MD
Cedars-Sinai Smidt Heart Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”